CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-05-24 | Clendeninn Neil James Director | Grant or award · Restricted Stock Unit (RSU) | +2,500 | 2,500 | ||
| 2013-05-23 | Smith David V Director | Option exercise | +2,000 | $10.64 | $21K | 2,000 |
| 2013-05-23 | Smith David V Director | Option exercise · Restricted Stock Unit (RSU) | −0 | 0 | ||
| 2013-05-23 | PARKER H STEWART Director | Option exercise | +2,000 | $10.64 | $21K | 5,000 |
| 2013-05-23 | PARKER H STEWART Director | Option exercise · Restricted Stock Unit (RSU) | −2,000 | 0 | ||
| 2013-05-23 | MATTINGLY MARTIN A Director | Option exercise | +2,000 | $10.64 | $21K | 3,000 |
| 2013-05-23 | MATTINGLY MARTIN A Director | Option exercise · Restricted Stock Unit (RSU) | −2,000 | 0 | ||
| 2013-05-23 | GOLDSTEIN JACK Director | Option exercise | +2,000 | $10.64 | $21K | 3,000 |
| 2013-05-23 | GOLDSTEIN JACK Director | Option exercise · Restricted Stock Unit (RSU) | −2,000 | 0 | ||
| 2013-05-23 | Clendeninn Neil James Director | Option exercise | +2,000 | $10.64 | $21K | 9,562 |
| 2013-05-23 | Clendeninn Neil James Director | Option exercise · Restricted Stock Unit (RSU) | −2,000 | 0 | ||
| 2013-03-12 | JACOBS CINDY EVP, CMO | Sale | −534 | $11.90 | $6K | 22,551 |
| 2013-03-12 | Cormack Scott Daniel President and CEO | Sale | −2,134 | $11.90 | $25K | 56,788 |
| 2013-03-12 | Wyrick Susan D. PAO | Grant or award · Stock Option (right to buy) | +4,125 | 4,125 | ||
| 2013-03-12 | Wyrick Susan D. PAO | Grant or award · Restricted Stock Unit (RSU) | +2,063 | 2,063 | ||
| 2013-03-12 | Wyrick Susan D. PAO | Grant or award · Restricted Stock Unit (RSU) | +5,000 | 5,000 | ||
| 2013-03-12 | JACOBS CINDY EVP, CMO | Option exercise | +1,875 | 23,085 | ||
| 2013-03-12 | JACOBS CINDY EVP, CMO | Shares withheld for taxes | −534 | 22,551 | ||
| 2013-03-12 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −1,875 | 5,625 | ||
| 2013-03-12 | JACOBS CINDY EVP, CMO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 31 of 36 · 715 trades